Home » Topics » BioWorld Science

BioWorld Science
RSS

New STAT5 inhibitors synthesized at Janpix

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

New STING agonists identified at The Scripps Research Institute

March 31, 2022

Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

Protein is marker, target for diabetic neuropathy

March 30, 2022

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

March 30, 2022

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

March 30, 2022

Cybin completes in vivo studies for deuterated psilocybin analogue CYB-003 for MDD

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...